Table 2.
Comparison between biliary atresia patients without and with jaundice.
| Variables | BA Patients without jaundice (n = 40) |
BA Patients with Jaundice (n = 20) |
P-value |
|---|---|---|---|
| Age (years) | 9.6 ± 0.9 | 9.5 ± 1.1 | 0.5 |
| Gender (Female: Male) | 20:20 | 12:8 | 0.5 |
| BMI (kg/m2) | 18.2 ± 0.6 | 17.1 ± 0.6 | 0.1 |
| Albumin (g/dl) | 4.5 ± 0.1 | 3.9 ± 0.1 | <0.001 |
| Total bilirubin (mg/dl) | 0.7 ± 0.1 | 6.5 ± 1.2 | <0.001 |
| Direct bilirubin (mg/dl) | 0.4 ± 0.1 | 5.9 ± 1.2 | <0.001 |
| AST (IU/l) | 98.3 ± 11.6 | 187.7 ± 18.2 | <0.001 |
| ALT (IU/l) | 94.1 ± 9.7 | 140.3 ± 24.5 | 0.04 |
| ALP (IU/l) | 369.8 ± 34.8 | 553.6 ± 33.9 | <0.001 |
| Platelet count (103/mm3) | 183.5 ± 15.5 | 121.2 ± 19.9 | 0.01 |
| APRI | 1.9 ± 0.4 | 5.0 ± 0.5 | <0.001 |
| Adiponectin (μg/ml) | 11.0 ± 0.7 | 24.4 ± 1.4 | <0.001 |
| Hyaluronic acid (ng/ml) | 28.9 ± 3.4 | 93.2 ± 16.7 | <0.001 |
| Liver stiffness (kPa) | 18.5 ± 2.4 | 53.3 ± 4.3 | <0.001 |
The data was expressed as mean ± SEM. BA, biliary atresia; BMI, body mass index; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; APRI, aspartate aminotransferase to platelets ratio index